Exosens Shares Rise by 2.08% at Midday This Wednesday
Exosens shares traded at 54.00 euros at midday on Wednesday, January 7, 2026, marking a 2.08% increase from the previous closing price of 52.90 euros. Despite limited trading volumes, the stock has shown significant growth over the past week and year, bolstered by a major contract with Theon International.
Current Session Overview
Exosens shares are trading at 54.00 euros at midday this Wednesday, up 2.08% from the previous close of 52.90 euros. Trading volumes remain low with only 0.07% of the capital traded, reflecting a quiet session at the start of the year. This increase is part of a dynamic weekly movement, with the stock achieving an 11.34% gain over the last seven days, marking a strong recovery after the end-of-year holidays. Over a broader horizon, the defense optronics specialist maintains an impressive upward trajectory with a performance of 26.02% over three months and a spectacular jump of 167.9% over one year. This exceptional growth is largely due to the historic contract secured in mid-December with Theon International to supply 200,000 light intensifier tubes to the German and Belgian armed forces, worth over 500 million euros. The order book strengthens in a European geopolitical context marked by increased defense budgets. The resistance threshold is now at 52.90 euros, crossed during the session, while the support remains anchored at 41.00 euros, offering a comfortable safety margin of 24% in case of a decline.
Technical Indicators and Market Behavior
The stock is significantly above its key moving averages, with a price of 54.00 euros surpassing the 50-day moving average at 46.18 euros and the 200-day average at 41.46 euros. This configuration indicates a bullish trend both in the short and long term. The RSI reaches 70, the overbought threshold, suggesting that the momentum remains strong but the stock might need a technical consolidation phase before continuing its upward movement. This reading is confirmed by a Stochastic sell signal, indicating potential short-term exhaustion. The MACD shows a line at 1.58 above its signal line at 0.93, with a positive histogram of 0.65, confirming the persistence of a bullish dynamic. Bollinger Bands frame the price between 43.01 euros for the lower bound and 52.16 euros for the upper bound. The stock thus moves slightly above the upper band, indicating an extension of volatility characteristic of a vigorous rally. The monthly volatility stands at 13.25%, a measured level considering the annual rise amplitude, while a beta of less than -0.31 confirms a largely decoupled evolution from Parisian indices.
Analyst Opinions and Company Outlook
Analyst opinions remain divided on Exosens' valuation following recent target price adjustments. On December 19, Kepler Cheuvreux revised its recommendation from Reduce to Hold, raising its target from 33.00 to 47.20 euros. This revision came after the announcement of the mega-contract with Theon and the revision of profit outlooks, but the target is now below the current price of 54.00 euros, suggesting caution on the valuation levels reached. Conversely, JPMorgan maintains an overweight recommendation with a target raised from 54.00 to 60.00 euros on December 10, offering an upside potential of 11% compared to the price this Wednesday. BNP Paribas keeps an outperform opinion with a target at 49.00 euros, also surpassed by the current price. Operationally, the group posted solid results at the end of October with a turnover of 327.8 million euros for the first nine months of 2025, up 23.2% year-on-year. Management is targeting annual growth at the higher end of the 15-20% range and an adjusted EBITDA growth at the lower end of the 20-25% range. The expansion of production capacities by 40% by 2027 and the commercialization of fifth-generation tubes are the next catalysts expected in a structurally supportive European defense market.
